GlassScriptPhysician profile
Kavit Shah
NPI 1730507930
$26,555.28
in general payments reported to CMS, 2019-2025
10 companies · $25K in 2025
The $25K reported for 2025 was more than what 95% of Vascular Neurology providers received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,103 · 2020: $11.98 · 2021: $39.58 · 2024: $23.10 · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Consulting Fee: $9,875 · Food and Beverage: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,300.00 |
| Consulting Fee | $9,875.00 |
| Food and Beverage | $226.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaneka Medical America LLC | $15,300.00 | 2025 | Apheresis Machine |
| Scientia Vascular | $5,000.00 | 2025 | |
| Imperative Care, INC | $2,578.08 | 2025 | Zoom 88-T Large Distal Platform, Zoom 7x Catheter |
| Qapel Medical INC | $2,500.00 | 2025 | |
| Genzyme Corporation | $1,000.00 | 2019 | |
| Biogen, INC. | $102.54 | 2019 | |
| Microvention, INC. | $23.34 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.10 | 2024 | |
| Medtronic, INC. | $14.96 | 2021 | |
| Penumbra, INC. | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.